NCT03346499View on ClinicalTrials.gov

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 9, 2017

Primary Completion Date

November 13, 2018

Study Completion Date

November 13, 2018

Conditions
HIV
Interventions
BIOLOGICAL

NK cells and IL-2

Natural Killer Cells

Trial Locations (1)

55455

University of Minnesota Medical Center, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03346499 - Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2 | Biotech Hunter | Biotech Hunter